SCHEMBL19246727

SCHEMBL19246727

c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccc6c7ccccc7n(-c7ccccc7)c6c54)cc3)nc3c2oc2ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.45
TSHR P16473 5/20 0.45
ALDH1A1 P00352 7/20 0.43
KDM4E B2RXH2 3/20 0.43
POLB P06746 3/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 5/20 0.42
HSD17B10 Q99714 3/20 0.42
MAPK1 P28482 2/20 0.42
NPSR1 Q6W5P4 4/20 0.42
KMT2A Q03164 7/20 0.41
MEN1 O00255 6/20 0.41
USP2 O75604 1/20 0.41
HTT P42858 1/20 0.41
ALOX12 P18054 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19247645 1.00 MAPT (0.45) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19247644 0.94 MAPT (0.43) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19246726 0.94 MAPT (0.43) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL24278929 0.93 MAPT (0.40) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL16905787 0.92 TSHR (0.49) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19248073 0.92 MAPT (0.41) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19246810 0.92 MAPT (0.41) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19247092 0.92 MAPT (0.41) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL18708374 0.92 MAPT (0.41) MAPTTSHRALDH1A1KDM4EPOLB
SCHEMBL19247727 0.92 MAPT (0.42) MAPTTSHRALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, ARL1 MAPT 1277/4885TSHR 3601/4885ALDH1A1 139/4885
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNA1, ARL1 MAPT 1277/4885TSHR 3601/4885ALDH1A1 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.